NuCana (NCNA) Enterprise Value (QoQ) (2017 - 2025)
NuCana (NCNA) Enterprise Value (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
NuCana |
29.13 Bn |
29.13 Bn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
1.42% |
| Sep 30, 2025 |
27.01% |
| Jun 30, 2025 |
-150.61% |
| Mar 31, 2025 |
42.52% |
| Dec 31, 2024 |
61.29% |
| Sep 30, 2024 |
-2.94% |
| Jun 30, 2024 |
-33.19% |
| Mar 31, 2024 |
23.65% |
| Dec 31, 2023 |
59.73% |
| Sep 30, 2023 |
-1.22% |
| Jun 30, 2023 |
-2.95% |
| Mar 31, 2023 |
-3.63% |
| Dec 31, 2022 |
17.81% |
| Sep 30, 2022 |
21.19% |
| Jun 30, 2022 |
6.15% |
| Mar 31, 2022 |
0.46% |
| Dec 31, 2021 |
17.04% |
| Sep 30, 2021 |
19.81% |
| Jun 30, 2021 |
-1.36% |
| Mar 31, 2021 |
-4.43% |
